by Corey Iacono | Nov 21, 2022 | Featured, Thinking Out Loud -Blog
Dogs Rule! (Cat Lovers Move Over) Seriously, what could be happier than a dog in a bike basket? The owner does all the work while Jack savors the ride! In my next life, I’m coming back as a Dutch dog. Seriously! In Vondelpark (Amsterdam) dogs gambol...
by Riley Nolan | Nov 10, 2022 | Events, Featured
A big THANK YOU to everyone who participated in the EpiVax’s 2022 Immunogenicity & Tolerance Seminar in Willemspark, Amsterdam, organized with Corine Kruiswijk of Intravacc. We learned about the importance of tissue-resident T memory cells, new developments in...
by Riley Nolan | Oct 31, 2022 | Featured, News
EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine PROVIDENCE, RI, October 31, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for...
by Corey Iacono | Oct 20, 2022 | Featured, Thinking Out Loud -Blog
The Epi-Team takes over PharmSci360 in Boston! That’s right! The Epi-Team was out in force at the annual AAPS PharmSci 360 meeting this week in the beautiful and historic city of Boston. Special thanks to Amy Rosenberg for moderating the discussion at my talk...
by Riley Nolan | Oct 17, 2022 | Events, Featured
We had a blast at AAPS PharmSci 360 in Boston! Thank you to everyone that attended our talks and poster sessions, and stopped by our booth or cocktail reception at Legal Seafoods! Pictures below! Talks: Anne De Groot, M.D., EpiVax, Inc. Deimmunization and...
by Riley Nolan | Sep 22, 2022 | Featured, Thinking Out Loud -Blog
FDA Awards $2M in Funding to EpiVax Host Cell Protein Study Remember when the CHO genome sequence came out? Ok, so you don’t, but we do! We built an app for that (see our paper entitled “Of [Hamsters] and Men”) and so, we will now perform validating...
